| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/25/2009 | CN100471946C Process for the biological production of 1,3-propanediol with high yield |
| 03/25/2009 | CN100471872C Optimizing fusion protein containing VEGF recerver segment and medical application thereof |
| 03/25/2009 | CN100471868C Compositions and methods for WT1 specific immunotherapy |
| 03/25/2009 | CN100471862C Antisense oligonucleotides that inhibit expression of HIF-1 |
| 03/25/2009 | CN100471861C Rapid extraction of RNA from cells and tissues |
| 03/25/2009 | CN100471522C Polynucleotide compsn. method of prepn. and use thereof |
| 03/24/2009 | US7507876 regulatory polynucleotide isolated from Nicotiana tabacum, Arabidopsis thaliana, and Medicago truncatula useful for modulating transgene expression in plants; herbicide resistance |
| 03/24/2009 | US7507875 transforming plant cells with a DNA construct comprising nucleic acid sequences, Eucalyptus caffeic acid 3-O-methyltransferase (COMT) promoters and nucleic acid sequence that code for polypeptides, then culturing said transformed plant cells, to producing transgenic plants |
| 03/24/2009 | US7507872 Transgenic toll-like receptor 9 (TLR9) mice |
| 03/24/2009 | US7507871 Rat model of diabetic nephropathy |
| 03/24/2009 | US7507811 siRNA targeting KRAS |
| 03/24/2009 | US7507810 Compositions and their uses directed to IL-4R alpha |
| 03/24/2009 | US7507809 RNAi modulation of RSV and therapeutic uses thereof |
| 03/24/2009 | US7507808 Modulation of endothelial lipase expression |
| 03/24/2009 | US7507807 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for use in identifying modulators for treatment of inflammatory, cardiovacullar, vision and cancer disorders |
| 03/24/2009 | US7507806 Nucleic acid sequences of human Rif1 |
| 03/24/2009 | US7507803 Optimized multi-epitope constructs and uses thereof |
| 03/24/2009 | US7507801 therapies and screening methods for a variety of disorders including but not limited to: myeloid malignancies such as acute myelogenous leukemia, myelodysplastic syndrome, polycythemia vera and juvenile chronic myelogenous leukemia; autoimmune diso |
| 03/24/2009 | US7507798 Antibody specific for mutant presenilin 1 |
| 03/24/2009 | US7507797 Single-chain antibody acting against 37 kDa/67 kDa Iaminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereof |
| 03/24/2009 | US7507796 Bivalent monomeric Fv antibody formed by one single-chain Fv monomer having four variable domains; expression plasmids which code for an Fv antibody; diagnosis; stability; no undesired immune response; side effect reduction; lack constant domains |
| 03/24/2009 | US7507795 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 03/24/2009 | US7507793 Mammalian sweet taste receptors t1r3 |
| 03/24/2009 | US7507792 MDA-7 proteins and methods of use thereof |
| 03/24/2009 | US7507752 A C9-deoxomeridamycin, used as a neuroregenerative agent |
| 03/24/2009 | US7507706 Administering a polypeptide to reduce airway hyper responsiveness or reduce the increase of mucus-containing cells in the airway epithelium; IL-13 binding chains of the interleukin-13 receptor |
| 03/24/2009 | US7507705 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 03/24/2009 | US7507580 Ztnfr14, a tumor necrosis factor receptor |
| 03/24/2009 | US7507576 Method of manufacturing probe carrier |
| 03/24/2009 | US7507574 Recombinant Saccharomyces cerevisiae expressing chimeric glucose transporters |
| 03/24/2009 | US7507573 Genetically engineered methylotrophic yeast for use as bioreactor in production of glycoproteins with mammalian-like glycosylation |
| 03/24/2009 | US7507570 Recombinant chondroitinase ABC I and uses thereof |
| 03/24/2009 | US7507569 hydrolase enzymes comprising amino acid sequence having replacements, deletions or insertion , used in cleaning compounds or detergents having improved wash performance on egg stains |
| 03/24/2009 | US7507567 RNA polymerase mutants with increased thermostability |
| 03/24/2009 | US7507566 Flavone synthases, methods of using flavone synthases, and plants expressing flavone synthases |
| 03/24/2009 | US7507557 Nucleotide sequences coding proline utilization protein (PUT2) for use as tool in prevention and treatment of insulin metabolic disorders |
| 03/24/2009 | US7507549 Method for following the progress of prostate cancer |
| 03/24/2009 | US7507546 Using intestinal peptide transporter (PEPT1) and/or kidney peptide transporter (PEPT2) to identify modulators which prevent transfer of sarcosine-glycine dipeptide across cells; drug delivery |
| 03/24/2009 | US7507544 Comprises nucleotide sequences coding mammalian taste-cell-specific G protein-coupled receptors for use in identifying agents which modify chemosensory taste transduction; sweetness and food processing |
| 03/24/2009 | US7507542 Autoimmune diseases; inflammatory bowel disease; multiple sclerosis; rheumatic diseases; modulate gene expression |
| 03/24/2009 | US7507541 36P6D5: secreted tumor antigen |
| 03/24/2009 | US7507529 genetic amplification of a target nucleic acid in biological samples containing primate T-lymphotropic viruses (PTLVs), include human and simian T-lymphotropic viruses (HTLV and STLV), and detecting the strain of PTLV contained in the sample by determining nucleotide fragments that have been amplified |
| 03/24/2009 | US7507528 Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells |
| 03/24/2009 | US7507415 West nile virus vaccine |
| 03/24/2009 | US7507414 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 03/24/2009 | US7507412 for drug screening; kits for collagen and/or platelet-collagen interaction; for treatment of thrombotic and cardiovascular events and disorders |
| 03/24/2009 | US7507408 Anti hepatitis C virus antibody and uses thereof |
| 03/24/2009 | US7507403 drugs comprising an isolated protein, mixed with pharmaceutically acceptable carriers, excipients or diluents, used as an immunogenic composition for stimulating or enhancing the production of antibodies directed against the protein |
| 03/24/2009 | CA2466877C Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 03/24/2009 | CA2407894C Clearance of ras-mediated neoplastic cells from mixed cellular compositions using reovirus |
| 03/24/2009 | CA2407715C Diagnostics and therapeutics for macular degeneration-related disorders |
| 03/24/2009 | CA2354635C Sequencing method using magnifying tags |
| 03/24/2009 | CA2320717C Method for the treatment of diseases or disorders of the inner ear |
| 03/24/2009 | CA2318479C G protein-related kinase mutants in essential hypertension |
| 03/24/2009 | CA2316975C Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugate vaccines |
| 03/24/2009 | CA2304260C Method for determining a concentration of target nucleic acid molecules, nucleic acid probes for the method and method for analyzing data obtained by the method |
| 03/24/2009 | CA2258802C Conjugates of an oligonucleotide/electronic conductor polymer with a molecule of interest, and their uses |
| 03/24/2009 | CA2231501C Method for precipitating nucleic acid with visible carrier |
| 03/24/2009 | CA2199853C Microorganisms and methods for overproduction of dahp by cloned pps gene |
| 03/24/2009 | CA2017186C Bacillus thuringiensis isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins |
| 03/23/2009 | CA2701047A1 Antibody against anthrax toxins |
| 03/21/2009 | CA2602876A1 Tissue culture and cloning things |
| 03/19/2009 | WO2009036385A2 Expression of nucleic acid sequences for production of biofuels and other products in algae and cyanobacteria |
| 03/19/2009 | WO2009036379A2 Rationally designed, synthetic antibody libraries and uses therefor |
| 03/19/2009 | WO2009036338A2 Methods for addressing ocular diseases through interference with the wnt signaling pathway |
| 03/19/2009 | WO2009036336A2 Biomarkers for motor neuron disease |
| 03/19/2009 | WO2009036299A2 Compositions and methods for the identification of inhibitors of retroviral infection |
| 03/19/2009 | WO2009036280A1 Long-term in vivo transgene expression |
| 03/19/2009 | WO2009036236A1 Mirna expression in human peripheral blood microvesicles and uses thereof |
| 03/19/2009 | WO2009036234A1 Synthetic axmi-004 delta-endotoxin genes and methods for their use |
| 03/19/2009 | WO2009036228A2 Hepatitis b pre-s2 nucleic acid |
| 03/19/2009 | WO2009036137A1 Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type i interferon response |
| 03/19/2009 | WO2009036095A1 Engineered light-harvesting organisms |
| 03/19/2009 | WO2009036067A2 Molecule production by photosynthetic organisms |
| 03/19/2009 | WO2009036063A1 Pseudotyped retroviral vectors and methods of making and using them |
| 03/19/2009 | WO2009036037A1 Regulatory elements associated with cbf transcription factors from maize |
| 03/19/2009 | WO2009035971A2 Compositions and methods for preventing influenza infection in canines, felines and equines |
| 03/19/2009 | WO2009035852A2 Increased alpha-prime beta-conglycinin soybeans |
| 03/19/2009 | WO2009035651A1 Wheat lines and improved food compositions |
| 03/19/2009 | WO2009035595A1 Plasmids from thermophilic organisms, vectors derived therefrom, and uses thereof |
| 03/19/2009 | WO2009035554A2 Superior structure stability and selectivity of hairpin nucleic acid probes with an l-dna stem |
| 03/19/2009 | WO2009035500A1 Trichoderma promoter |
| 03/19/2009 | WO2009035357A2 Immunological tests for the presence of bacteria which make use of antibodies obtained using a specific method |
| 03/19/2009 | WO2009035205A1 TRANSFORMED PLANT EXPRESSING β-SITE APP CLEAVING ENZYME (BACE) |
| 03/19/2009 | WO2009035170A1 Method for diagnosis and induction of resistance to virus |
| 03/19/2009 | WO2009035107A1 Method for production of non-natural antibiotic |
| 03/19/2009 | WO2009034842A1 Nucleic acid detection method, and nucleic acid detection kit |
| 03/19/2009 | WO2009034790A1 Fluorescent molecule |
| 03/19/2009 | WO2009034779A1 Cancer diagnosis kit and cancer diagnosis method |
| 03/19/2009 | WO2009034395A1 Method and means relating to multiple herbicide resistance in transgenic plants |
| 03/19/2009 | WO2009034328A2 Two step cluster deletion and humanisation |
| 03/19/2009 | WO2009034319A2 Magnetic delivery device |
| 03/19/2009 | WO2009034190A2 Affinity tag |
| 03/19/2009 | WO2009034188A1 Plants having increased yield-related traits and a method for making the same |
| 03/19/2009 | WO2009034182A1 Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use |
| 03/19/2009 | WO2009034159A1 Short polypeptide mediated conformational changes promoting enhancement of enzymatic activity |
| 03/19/2009 | WO2009034158A2 Transgenic mice |
| 03/19/2009 | WO2009034127A1 Use of the cyp46a1 gene for the treatment of alzheimer's disease |
| 03/19/2009 | WO2009034103A1 Leukotriene b4 binding soluble lipocalin receptor from ixodes ricinus |
| 03/19/2009 | WO2009033876A1 Aptamers labeled with 18f |